Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 25 ... food, tuition, course materials, activities and field trips is US $2950. Limited partial scholarship funding is available in 2010 for students selected with demonstrated ... (PSGE). Action to continue the innovative summer program was made by Lehigh in response to parental concern about the closure of all eight program locations across the state ...
2009 NOV 25 ... from similar clinical studies with drugs currently on the market - suggest the partial agonist profile of aplindore would not be differentiated from the full agonists which ... which did not reach statistical significance, resulting in a "V"-shaped dose-response curve. The most common adverse events included nausea, somnolence, headache, and ...
2009 NOV 23 ... with extrapulmonary metastasis. Four patients of complete response and 12 patients of partial response were confirmed, given an overall response rate of 37.2% (95% confidence interval, ...
2009 NOV 24 ... free from both the displacement noise of optics and laser frequency noise. So far, partial experimental demonstrations of the DFI have been done in 2D table top ... Ochanomizu University.The researchers concluded: "The nonvanishing DFI response to a gravitational wave was successfully confirmed using multiple electro-optic ...
2009 NOV 24 ... hormone-induced transcription, and (ii) the GR antagonist RU486 is converted into a partial agonist in the presence of FoxA1 via ligand-independent GR activation," wrote S. ... were shown to act in concert, to direct the chromatin structure, and to enhance the GR response," scientists writing in the journal Molecular and Cellular Biology report. ...
2009 NOV 23 ... a mild increase in type I cytokine levels was observed in complete responders versus partial/nonresponders, which became highly significant after completion of therapy and remained ... and after neoadjuvant chemoradiation, and assessed their correlation with therapeutic response," scientists in New Delhi, India report. "Ninety patients with advanced ...
2009 NOV 23 ... gradient (PPG) > 25%, further dilatation was not proposed. Either complete or partial response was obtained in 58%, 81%, 83%, and 93% of patients at 1, 3, 6, and 12 months, ...
2009 NOV 23 ... 10 patients in Group A and 13 in Group B. Group A: Nine complete remissions (CR) and one partial remission (PR) were achieved following BEACOPP treatment. After a median follow-up of 32 ... of patients with HL relapsed after or refractory to first-line therapy achieve a durable response after peripheral blood stem cell transplantation (PBSCT)," scientists in Rome, Italy ...
2009 NOV 23 ... was 3.5 (1-14). The response rate was 17.5% (95% confidence interval: 7.3-32.8%, partial response: 7, stable disease: 21, progressive disease: 10 and not evaluable: 2). The disease ...
2009 NOV 23 ... 77 out of 82 (94%) patients (75 patients had a complete response (91%), 2 patients had a partial response). With a median follow-up of 46 months, 7-year progression-free and overall survival ...
2009 NOV 23 ... (27%). After a median follow-up of 4.4 years, 24 patients (69%) showed complete or partial muscle remission. Only histological muscle inflammation was associated with good muscle ... analysis (odds ratio 44.7, 95% CI 2.8 to 704.7). without muscle inflammation had a poor response to corticosteroids (38% favourable response vs 90% in patients with inflammation)," ...
2009 NOV 24 ... The median follow-up time was 5 years. Based on the apnea-hypopnea index, a complete or partial response was obtained in 71% of the cases. The mean apnea-hypopnea index decreased significantly ...
2009 NOV 23 ... receptor (GR) for discriminating between patients who achieve complete remission, or partial remission, or who do not improve with glucocorticoid treatment." "We ... the R23K or N363S polymorphism. There was no evidence that this polymorphism influenced response to treatment with GC (Fisher's exact test 1.0). Expression of GR and the presence of ...
2009 NOV 23 ... or 4 nonhematologic events. The overall response rate was 100% (complete response, 91%; partial response, 9.0%) with a progression-free survival of 19 months. This outpatient regimen of IV and ...
2009 NOV 23 ... of Health. The researchers concluded: "The patient has an ongoing partial response at 10 months after the last treatment." Smith and colleagues published ...
2009 NOV 23 ... in other tumor types. Of the 62 patients at 1250 mg/m2, 1 complete response (1.6%), 4 partial response (6.5%) and 20 stable disease (32.3%) were achieved, yielding an RR of 8.1% (95% CI: ...
2009 NOV 23 ... time-of-flight mass spectrometry (Acquity UPLC-QTOFMS). Orthogonal partial least-squares discriminate analysis (OPLS-DA) models generated from GC-TOFMS and ... "Colorectal carcinogenesis involves the overexpression of many immediate-early response genes associated with growth and inflammation, which significantly alters downstream ...
2009 NOV 23 ... regeneration. In this study, we evaluated the impact of glove membranes, which provide a partial barrier and different water loss rates, on barrier recovery after standardized ... semipermeably covered showed an enhanced barrier recovery and a reduced inflammatory response compared to the area under occlusion and the control. During healing process, TEWL (p ...
2009 NOV 23 ... because one of the three patients who received S-1 as second-line chemotherapy showed a partial response," wrote Y. Seki and colleagues, National Cancer Center Hospital. The ...
2009 NOV 23 ... achieving CR (negative immunofixation and normal bone marrow) or at least very good partial response is associated with longer progression-free survival and in most studies longer ...
